Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Morayfield
Clinical trial register · Australia

Clinical Trials in Morayfield, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3348 matching records held by the registry are in this view. Synced 18 Oct 2026, 03:18 UTC
3348
Studies in scope
all four open statuses
1802
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1099 Adelaide 566 Sydney 511 Westmead 417 Clayton 408
Narrow the registerReset
Recruitment status
Phase
Site location
Melbourne1099 Adelaide566 Sydney511 Westmead417 Clayton408
All 399 locations
Target enrolment
to

Trials with a site in Morayfield

16 of 3348 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Massachusetts General Hospital
Phase 1
280
Sydney, Maroochydore, Morayfield, Camberwell
2027-02-03
Not yet open
A Phase 1 Study of VELA-101 in Adult Participants
NCT07864311Healthy Participants, Hyperlipidemia
Ursa Medicines
Phase 1
60
Morayfield, Nedlands
2026-11
Recruiting
HB BioTech, LLC
Phase 2
200
Deakin, Charlestown, Darlinghurst, Waitara, Westmead, Herston, Mackay, Morayfield
2026-06-03
Recruiting
Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
NCT07303777Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management
Atom Therapeutics Co., Ltd
Phase 2
200
Newcastle, Morayfield, Brisbane, Wahroonga
2026-04-23
Recruiting
Sanofi
Phase 1
570
Griffith, Herston, Morayfield, Sippy Downs, South Brisbane, Taringa
2026-04-15
Active, closed
Kailera
Phase 3
1,270
Bruce, Blacktown, Kanwal, Herston, Morayfield, South Brisbane, Camberwell
2025-12-30
Recruiting
Arrowhead Pharmaceuticals
Phase 1/2
78
Charlestown, Morayfield, East Melbourne, Melbourne, Perth, Clayton
2025-12-22
Recruiting
Study of DONQ52 in Active Celiac Disease
NCT07239336Celiac Disease
Chugai Pharmaceutical
Phase 2
92
Campbelltown, North Sydney, Morayfield, Sippy Downs, South Brisbane, Box Hill, Parkville, Midland
2025-12-16
Active, closed
Study of an RSV-hMPV-PIV3 Trivalent Vaccine Candidate VXB-251 in Older Adults
NCT07295028Lower Respiratory Tract Disease, Healthy Participants
Sanofi
Phase 1
240
Brisbane, Camberwell, Darlinghurst, Melbourne, Morayfield, Sippy Downs
2025-11-17
Recruiting
Ingenia Therapeutics INC
Phase 1/2
94
Herston, Gosford, Sydney, Morayfield, Saint Albans
2025-10-30
Recruiting
Doron Therapeutics Inc.
Phase 3
300
Botany, Broadmeadow, St Leonards, Birtinya, Maroochydore, Morayfield, Taringa, Tarragindi
2025-10-14
Recruiting
EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)
NCT07047703Axial Spondyloarthritis (AxSpA)
Grey Wolf Therapeutics
Phase 1/2
140
Birtinya, Morayfield, Perth, Sydney
2025-07-28
Recruiting
Arrowhead Pharmaceuticals
Phase 1/2
150
Morayfield, Nedlands
2025-05-09
Recruiting
Sanofi
Phase 1/2
1,560
Bruce, Maroubra, Sydney, Albion, Morayfield, Southport, Melbourne
2025-03-27
Active, closed
Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects
NCT06471543Hypertriglyceridemia, Familial Chylomicronemia Syndrome
Ikaria Bioscience Pty Ltd
Phase 1/2
108
Morayfield, Sippy Downs, Altona N., Melbourne
2024-09-30
Active, closed
Sanofi
Phase 1
144
Morayfield, Sippy Downs, South Brisbane, Bayswater
2024-08-13
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 October 2026. https://priyalifescience.com/clinical-trials-australia/city/morayfield

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,348 studies in total at the last sync on 18 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies with a site in Morayfield.

How many clinical trials are recruiting in Morayfield?

10 of the 16 studies on this page are recruiting new participants as of the 18 Oct 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Morayfield), 16 studies
PhaseStudiesRecruitingShare
Phase 1/26537.5%
Phase 15131.3%
Phase 23318.8%
Phase 32112.5%

Most active sponsors

Lead sponsors with the most studies (Morayfield)
Lead sponsorStudiesRecruiting
Sanofi42
Arrowhead Pharmaceuticals22
Atom Therapeutics Co., Ltd11
Chugai Pharmaceutical11
Doron Therapeutics Inc.11
Grey Wolf Therapeutics11
HB BioTech, LLC11
Ikaria Bioscience Pty Ltd10
Ingenia Therapeutics INC11
Kailera10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.